Mechanistic Correlates of Clinical Responses to Omalizumab in the Setting of Oral Immunotherapy for Milk Allergy

BACKGROUND: In our recent clinical trial, the addition of omalizumab to oral immunotherapy (OIT) for milk allergy improved safety but no significant clinical benefit was detected. OBJECTIVE: To investigate mechanisms by which omalizumab modulates immunity in the context of OIT, and to identify basel...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Allergy Clin Immunol
Hoofdauteurs: Frischmeyer-Guerrerio, Pamela A., Masilamani, Madhan, Gu, Wenjuan, Brittain, Erica, Wood, Robert, Kim, Jennifer, Nadeau, Kari, Jarvinen, Kirsi M., Grishin, Alexander, Lindblad, Robert, Sampson, Hugh A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632581/
https://ncbi.nlm.nih.gov/pubmed/28414061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2017.03.028
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items